$NDRA

Why ENDRA Life Sciences Shares Are Trading Higher By Over 61%; Here Are 20 Stocks Moving Premarket - Blue Gold (NASDAQ:BGL), BioSig Technologies (NASDAQ:BSGM)

Shares of ENDRA Life Sciences Inc. NDRA rose sharply in pre-market trading after the company announced it will be granted a US patent titled "Radio Frequency Applicator". ENDRA Life Sciences shares jumped 61.4% to $5.58 in the pre-market trading session. Here are some other stocks moving in ...

Original reporting
Benzinga · Avi Kapoor
Published Jul 8, 2025, 10:15 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 8, 2025, 10:31 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Why ENDRA Life Sciences Shares Are Trading Higher By Over 61%; Here Are 20 Stocks Moving Premarket - Blue Gold (NASDAQ:BGL), BioSig Technologies (NASDAQ:BSGM) — source image
Decision brief

The 30-second read

$NDRABullishMed
01

Why it matters

The patent grant is viewed positively by investors, leading to increased buying interest and a significant pre-market price surge.

02

Market read

The news is highly relevant within the biotech and medical technology sectors, potentially influencing related stocks and sector sentiment.

03

What to watch

Potential delays in patent approval process or commercialization; broader market corrections could offset gains; sector rotation might impact biotech stocks.

Timing: Immediate to short-term (next few days)

Background

ENDRA Life Sciences announced a US patent for 'Radio Frequency Applicator,' a development that could enhance its product portfolio and market competitiveness.

Company-level read

Ticker impact

$NDRABullishHigh confidence
Context

High relevance due to recent patent news and significant pre-market price jump.

Expected impact

Likely short-term upward momentum with potential for continued gains if patent approval translates into commercial success.

Evidence & confidence

The sharp pre-market rise and the significance of patent grants in biotech often lead to sustained investor interest, especially when accompanied by positive news.

Market effects

Potential positive sentiment boost for biotech and life sciences sectors, possibly leading to increased investor interest and funding activities.

Primarily US-focused, with potential ripple effects in global biotech markets due to patent significance.

Limited; impact mostly confined to US biotech sector and related markets.

Counterpoint

The sharp pre-market rise may be an overreaction; profit-taking could lead to a quick reversal, especially if the patent does not translate into immediate commercial benefits.

Key entities

  • ENDRA Life Sciences

    A biotech company focusing on medical imaging and related technologies.

  • US Patent Office

    The authority granting patents, indicating official recognition of intellectual property.

Related articles

$NDRAMed

ENDRA Life Sciences Inc. (NDRA): Results of Operations and Financial Condition

ENDRA Life Sciences Inc. (NDRA) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 August 17, 2026 ENDRA Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Update ANN ARBOR, Mich., (BUSINESS WIRE) – ENDRA Life Sciences Inc . (NASDAQ: NDRA) (“ENDRA” or the “Company”), a pioneer in thermoacoustic biomarker imaging for e

$NDRAMed

Noble Africa-ENDRA (NDRA) merger to create pure-play helium and LNG company

ASP Isotopes plans to merge its subsidiary Noble Africa, which holds South Africa’s Renergen helium and LNG project, with ENDRA Life Sciences to form a publicly listed helium platform called Noble Africa. ASP Isotopes expects ~89% ownership post-close. Management cites 1P helium reserves of 7.2 Bcf and targets Phase 1 output of ~70 Mcf/day helium and 2,500 GJ/day LNG, with estimated revenue and cash gross profit. Closing is targeted for Q4, subject to SEC review and approvals.

$GMEMed

GameStop president Ryan Cohen buys $26.4m in GME stock

GameStop's Ryan Cohen bought 1.15 million shares, totaling $26.4 million, at $22.76-$23.02 each. He now holds 40.5 million shares. GameStop has a $11.55B market cap, P/E of 15.06, and exchanged $1.4B in notes for stock. Earnings are due September 8, with expected 4.7% movement. Cohen expressed interest in acquiring eBay.

$BAMed

Boeing wins defense contracts worth $41.5m for aircraft support

Boeing Co. secured two defense contracts worth $41.5m. One, $11.8m, is for F/A-18E/F Super Hornet support services in Kuwait, funded via Foreign Military Sales. The other, $29.7m, covers V-22 aircraft data for maintenance. Work spans multiple U.S. locations, with completion dates in 2027 and 2030. Contracts were awarded without competition by Naval Air Systems Command.

$GMEMed

GameStop CEO Ryan Cohen buys 1.15M shares

GameStop Corp. (GME) reported that CEO Ryan Cohen purchased 1.15M shares of Class A common stock on September 21, 2026, at an average price of $22.94 per share. This brings his direct holdings to 40.5M shares. The transaction was an open-market or private purchase.